News Worms
News Worms

Novartis' CAR-T Drug Win Helps Gilead To Spike Post Kite Deal

Novartis' CAR-T Drug Win Helps Gilead To Spike Post Kite Deal

Novartis AG on Wednesday won highly anticipated USA approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers.

The Food and Drug Administration called the approval historic, the first gene therapy to hit the USA market. It is made from scratch for every patient. It is the first gene therapy to be allowed in the United States - a "historic" approval, the agency said. Those T cells then are infused back into the patient. It transforms a patient's immune system cells to fight a form of leukemia. With CAR-T, some T-cells are removed from a patient's blood.

Juno Therapeutics Inc previous year reported a handful of patient deaths during trials of its CAR-T therapy for leukemia.

"We're entering a new frontier in medical innovation with the ability to reprogram a patient's own cells to attack a deadly cancer", said FDA Commissioner Scott Gottlieb, MD.

In a pivotal study of five dozen patients, the drug induced remission in more than 80 percent.

"The theory is they should attack the tumor and continue to grow to become a long-term monitoring and treatment system", Lichtenfeld said. "Not only does Kymriah provide these patients with a new treatment option where very limited options existed, but a treatment option that has shown promising remission and survival rates in clinical trials". "I wouldn't say we know for sure how many will be cured yet by this therapy".

The treatment, which is expected to be costly, can cause serious side effects including high fevers and neurological problems. The FDA designated a treatment for those side effects Wednesday.

Dr. Kenneth Anderson is president of the American Society of Hematology, which focuses on blood cancers.

Kite's action date at the agency with its lead CAR-T medication, Axi-Cel, is in November.

"Unfortunately leukemia grows so rapidly that it can evade even the smartest of our technologies", he added. Novartis said it hopes to have an initial network of 20 treatment centers within a month with plans to expand that to 32 by the end of the year. Most of these symptoms should appear within three weeks of infusion with Kymriah, the FDA said. The $475,000 price tag doesn't include the cost of needed hospitalizations, travel to a certified hospital and other expenses.

Unlike traditional gene therapy, the new treatment doesn't replace disease-causing genes with healthy ones. Kymriah's maker, Novartis, hasn't provided a price for the drug. But if it's the last treatment they need, "that's a really significant one-time investment in their wellness, especially in kids who have a whole lifetime ahead of them". "This is a potentially curative therapy in patients whose leukemia is unresponsive to other treatments". "With the approval of Kymriah, we are once again delivering on our commitment to change the course of cancer care".

Manufacturing and delivery are more complex in CAR-T therapies than for a typical drug. Research is therefore focusing for now on refining the therapy for patients of this disease. "Approvals are an important step, but they're just the beginning".


editors' picks

August 31, 2017
Donald Trump Jr. to Testify to Senate Committee Behind Closed Doors
Paul Manafort worked for the pro-Kremlin Party of the Regions in Ukraine before joining the Trump campaign. . Chuck Grassley and ranking member Sen.

August 31, 2017
Twitter reacts to Florida now having 10 suspended players for MI opener
Desir-Jones saw playing time in two games last season on the offensive line, but switched to defensive line this season. Scarlett was Florida's starting running back, rushing for 889 yards and six touchdowns as a sophomore in 2016.

August 31, 2017
Merkel Calls On Turkey To Release Jailed German Citizens
Therefore, the defiant chancellor told the anti-refugee hecklers that under her leadership, Berlin still welcomes asylum-seekers. She stated this on Tuesday at an annual press conference, an Ukrinform correspondent reports from Germany .

August 31, 2017
Google Is Ready To Augment Our Reality With ARCore
Google is planning to roll out its ARCore software development kit to bring Augmented Reality (AR) to 100 million Android phones. Dave Burke, vice-president of Android engineering, said in a blog post that ARCore won't require new hardware.

August 31, 2017
Joel Osteen Responds to Claims He Closed Church to Hurricane Harvey Victims
At least nine people are reported to have died as a result of Hurricane Harvey, the worst storm to strike the USA in 12 years. Pastor Osteen's church is now open for evacuees, and he says flooding inside the church is the reason for the delay.

August 31, 2017
Andy Murray Withdraws from 2017 US Open Due to Hip Injury
He is the 30-year-old stunning player. "If it means I can play before the end of the year, then that's what I would love to do". I miss competing, and I'll try to get myself back on court as soon as I can.

August 31, 2017
Google Assistant is coming to third party speakers and appliances
On the top of the device you've got buttons for cycling through the various inputs, which include Bluetooth and a 3.5mm aux input. You get an Echo Dot-like design with buttons on top as well as a strap to easily carry the TicHome Mini with you everywhere.

August 31, 2017
Kathy Griffin is going global and no longer sorry
"The whole thing got so blown out of proportion", Griffin continued, "and I lost everybody". She may have lost her career, but the Fashion Police alum is not going down without a fight.

August 31, 2017
Packers, Ahmad Brooks Agree to 1-Year, $5 Million Deal
Both dropped out of last week's preseason game - Matthews with a groin injury and Perry with an sprained ankle. He notched at least six sacks per season dating back to 2011 when he became a full-time starter.

August 30, 2017
Why Was a Christian Child Forced into a Muslim Foster Home?
The Muslim carers also "encouraged" her to learn Arabic and told her that "Christmas and Easter are stupid". A friend of the young girl's family in Tower Hamlets told The Times , "This is a five-year-old white girl".